Italian registry of families at risk of pancreatic cancer: AISP Familial Pancreatic Cancer Study Group

Gabriele Capurso, Salvatore Paiella, Silvia Carrara, Giovanni Butturini, Erica Secchettin, Luca Frulloni, Alessandro Zerbi, Massimo Falconi

Research output: Contribution to journalArticlepeer-review


Pancreatic cancer is one of the main causes of cancer-related death worldwide, with a survival rate around 9%. In Italy 13,500 new cases of pancreatic cancer occurred in 2019. It is estimated that at least 5% have a hereditary background. Surveillance is advisable for healthy individuals with specific genetic syndromes with or without family history of pancreatic cancer or members of families with multiple cases of pancreatic cancer, irrespective of genetic syndromes. In 2010 the Italian Association for the Study of the Pancreas (AISP) defined criteria to include individuals in such surveillance programs with the first-round results published in 2019. In order to include other categories at high-risk and increase the diagnostic yield of surveillance, these criteria have recently been modified. The present position paper presents the updated criteria of the Italian Registry of Families at Risk of Pancreatic Cancer (IRFARPC) with their diagnostic yield calculation. Also, AISP priority projects concerning: (a) increasing awareness of citizens and primary care physicians through a dedicated App; (b) increasing access to germline testing to personalize surveillance; (c) measuring psychological impact of surveillance; (d) investigating the role of risk-modifiers and (e) evaluating the cost-effectiveness and ability to save lives of the program are briefly presented.

Original languageEnglish
Pages (from-to)1126-1130
Number of pages5
JournalDig. Liver Dis.
Issue number10
Publication statusPublished - Oct 2020


Dive into the research topics of 'Italian registry of families at risk of pancreatic cancer: AISP Familial Pancreatic Cancer Study Group'. Together they form a unique fingerprint.

Cite this